German health insurers prioritise medical technology
This article was originally published in Clinica
Executive Summary
If Germany's healthcare costs are to be kept under control, the current trend of introducing innovative and generally expensive medical technology into the reimbursement catalogue of the German statutory health insurance funds must be addressed. This is just one of the issues dealt with in a position paper on the future of the health service, launched last week by the leading groups of the statutory health insurance funds (GKV).